Bayer has bolstered its cell and gene therapy platform by securing access to a CRISPR-based gene-editing platform developed by US biotech Mammoth Biosciences. The German group is paying $40 ...

Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but its ...

Oppression and violent crimes against women especially stalking and murders surged in 2017 Incidents like the rape and murder of sevenyearold Hasini Chandru or more recently the immolation of 21yearol ...